Potential causes of weight gain in type 1 diabetes mellitus

被引:47
作者
Jacob, A. N. [1 ]
Salinas, K. [1 ]
Adams-Huet, B. [1 ]
Raskin, P. [1 ]
机构
[1] Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA
关键词
insulin therapy; ghrelin; type; 1; diabetes; weight gain;
D O I
10.1111/j.1463-1326.2005.00515.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To investigate the potential causes of weight gain with insulin therapy and improved diabetic control in type 1 diabetes mellitus. Methods: This was an open-label prospective study of insulin therapy of 6 months duration in an academic medical centre. Twenty-one subjects with type 1 diabetes were enrolled. The goal was to achieve an haemoglobin A1c (HbA1c) in the range of individuals without diabetes (< 5.6%). At baseline, 3 and 6 months, weight, resting energy expenditure, appetite assessment, food intake, activity level, HbA1c and 24-h glycosuria and urea nitrogen were measured. Plasma leptin, ghrelin and adiponectin levels and body fat were measured at baseline and 6 months. Results: At baseline, average weight was 73.7 +/- 17.4 kg and HbA1c was 10.0 +/- 2.2%. Weight increased by 2.15 kg (2.69% of baseline) by 6 months whereas the HbA1c dropped by 1.71% (16.3%) to 7.9%. Energy intake differences between 3 and 6 months had a negative correlation with weight gain, but the changes in glycosuria, appetite scores and the frequency of hypoglycaemia did not correlate with weight gain. Glycaemic control did not correlate with weight change but tended to correlate with fat mass increase (p = 0.064; r = -0.51). An increase in the activity levels between 3 and 6 months correlated with decreasing fat mass (p = 0.037; r = -0.74). The changes in the appetite scores had a negative correlation with fat mass gain (p = 0.035; r = -0.61). The changes in lean body mass correlated with protein and total energy intake (p = 0.007, r = 0.85 and p = 0.003, r = 0.73 respectively). The changes in leptin levels correlated with weight gain. Conclusions: The lipogenic effect of insulin with subsequent increase in fat mass may be the primary cause of this weight gain that can be attenuated by the increases in the activity levels. The negative correlation of energy intake and appetite scores with fat mass gain suggests that they do not play a significant role in fat mass gain whereas energy intake did correlate with lean body mass gain.
引用
收藏
页码:404 / 411
页数:8
相关论文
共 16 条
  • [1] Compendium of Physical Activities: an update of activity codes and MET intensities
    Ainsworth, BE
    Haskell, WL
    Whitt, MC
    Irwin, ML
    Swartz, AM
    Strath, SJ
    O'Brien, WL
    Bassett, DR
    Schmitz, KH
    Emplaincourt, PO
    Jacobs, DR
    Leon, AS
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2000, 32 (09) : S498 - S516
  • [2] Effects of metformin in patients with poorly controlled insulin-treated type 2 diabetes mellitus -: A randomized, double-blind, placebo-controlled trial
    Avilés-Santa, L
    Sinding, J
    Raskin, P
    [J]. ANNALS OF INTERNAL MEDICINE, 1999, 131 (03) : 182 - +
  • [3] INTENSIVE INSULIN THERAPY AND WEIGHT-GAIN IN IDDM
    CARLSON, MG
    CAMPBELL, PJ
    [J]. DIABETES, 1993, 42 (12) : 1700 - 1707
  • [4] DCCT Res Grp, 1988, DIABETES CARE, V11, P567
  • [5] GLUCOSE AND FREE FATTY-ACID TURNOVER IN NORMAL SUBJECTS AND IN DIABETIC-PATIENTS BEFORE AND AFTER INSULIN-TREATMENT
    HALL, SEH
    SAUNDERS, J
    SONKSEN, PH
    [J]. DIABETOLOGIA, 1979, 16 (05) : 297 - 306
  • [6] GENERALIZED EQUATIONS FOR PREDICTING BODY DENSITY OF MEN
    JACKSON, AS
    POLLOCK, ML
    [J]. BRITISH JOURNAL OF NUTRITION, 1978, 40 (03) : 497 - 504
  • [7] JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175
  • [8] NAIR KS, 1984, DIABETOLOGIA, V27, P13, DOI 10.1007/BF00253494
  • [9] EFFECT OF POOR DIABETIC CONTROL AND OBESITY ON WHOLE-BODY PROTEIN-METABOLISM IN MAN
    NAIR, KS
    GARROW, JS
    FORD, C
    MAHLER, RF
    HALLIDAY, D
    [J]. DIABETOLOGIA, 1983, 25 (05) : 400 - 403
  • [10] Minireview: Human obesity - Lessons from monogenic disorders
    O'Rahilly, S
    Farooqi, IS
    Yeo, GSH
    Challis, BG
    [J]. ENDOCRINOLOGY, 2003, 144 (09) : 3757 - 3764